Cargando…
Therapeutic protein drug products : practical approaches to formulation in the laboratory, manufacturing, and the clinic /
Therapeutic protein drug products provides a comprehensive overview of therapeutic protein drug products, with an emphasis on formulation beginning in the laboratory, followed by manufacturing and administration in the clinic. A list of many commercial therapeutic drug products are described and inc...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Woodhead Pub.,
2012.
|
| Colección: | Woodhead Publishing series in biomedicine ;
no. 8. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn847549881 | ||
| 003 | OCoLC | ||
| 005 | 20231117044903.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 130114s2012 enka ob 001 0 eng d | ||
| 010 | |a 2012551083 | ||
| 040 | |a E7B |b eng |e pn |c E7B |d OCLCO |d OHS |d IDEBK |d N$T |d OPELS |d MYG |d OCLCF |d OTZ |d OCLCQ |d OCLCO |d UIU |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d UAB |d U3W |d OCLCO |d D6H |d OCLCQ |d OCLCO |d OCLCA |d AUD |d DCT |d ESU |d S2H |d OCLCO |d LUN |d LVT |d OCLCO |d OCLCQ |d CASUM |d OCL |d OCLCO | ||
| 015 | |a GBB0D7048. |2 bnb | ||
| 019 | |a 875291009 |a 972074723 |a 1039528078 |a 1043393564 |a 1055240407 |a 1086500926 |a 1171124213 |a 1172088661 |a 1229225245 | ||
| 020 | |a 9781908818102 |q (electronic bk.) | ||
| 020 | |a 1908818107 |q (electronic bk.) | ||
| 020 | |z 9781907568183 | ||
| 020 | |z 1907568182 | ||
| 035 | |a (OCoLC)847549881 |z (OCoLC)875291009 |z (OCoLC)972074723 |z (OCoLC)1039528078 |z (OCoLC)1043393564 |z (OCoLC)1055240407 |z (OCoLC)1086500926 |z (OCoLC)1171124213 |z (OCoLC)1172088661 |z (OCoLC)1229225245 | ||
| 050 | 4 | |a RS431.P75 |b T44 2012eb | |
| 060 | 4 | |a QV 778 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a TC |2 bicssc | |
| 072 | 7 | |a TEC |2 eflch | |
| 082 | 0 | 4 | |a 615.19 |2 22 |
| 245 | 0 | 0 | |a Therapeutic protein drug products : |b practical approaches to formulation in the laboratory, manufacturing, and the clinic / |c edited by Brian K. Meyer. |
| 260 | |a Oxford : |b Woodhead Pub., |c 2012. | ||
| 300 | |a 1 online resource (xxii, 181 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Woodhead Publishing series in biomedicine, |x 2050-0289 ; |v no. 8 | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Therapeutic protein drug products provides a comprehensive overview of therapeutic protein drug products, with an emphasis on formulation beginning in the laboratory, followed by manufacturing and administration in the clinic. A list of many commercial therapeutic drug products are described and include the product name, dosages, active concentration, buffer, excipients, Ph, container type and route of administration. The laboratory formulation sections focus on the most common buffers, excipients, and Ph ranges that are commonly tested in addition to systematic approaches. A brief section on biophysical and analytical analysis is also provided. Properties of therapeutic protein formulations are described and include opalescence, phase separation, color, and subvisible particles. An emphasis is placed on material and process testing to ensure success during manufacturing. The drug product manufacturing process, which includes the process of compounding to filling, is also covered. Methods of delivery in the clinic are addressed, as well as delivery strategies. Finally, a perspective on the regulatory requirements for therapeutic protein formulations is discussed. Provides a list and description of commercially available therapeutic drug products and their formulationsA comprehensive and practical overview of protein formulation in the laboratory, manufacturing, and the clinicDiscusses recent topics including high protein concentration, phase separation, opalescence, and subvisible particles. | ||
| 505 | 0 | |a Commercial therapeutic protein drug products -- A formulation method to improve the physical stability of macromolecular-based drug products -- Properties of protein formulations -- Material and process compatibility testing -- Compounding and filling: Drug substance to drug product -- Administration in the clinic -- Regulatory guidelines for the development of a biotechnology drug product. | |
| 650 | 0 | |a Protein drugs. | |
| 650 | 0 | |a Protein drugs |x Dosage forms. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Proteins. | |
| 650 | 0 | |a Drugs |x Dosage forms. | |
| 650 | 2 | |a Drug Design |0 (DNLM)D015195 | |
| 650 | 2 | |a Proteins |0 (DNLM)D011506 | |
| 650 | 2 | |a Biopharmaceutics |x methods |0 (DNLM)D001702Q000379 | |
| 650 | 2 | |a Dosage Forms |0 (DNLM)D004304 | |
| 650 | 6 | |a M�edicaments prot�eiques. |0 (CaQQLa)201-0249096 | |
| 650 | 6 | |a M�edicaments prot�eiques |x Formes pharmaceutiques. |0 (CaQQLa)201-0263778 | |
| 650 | 6 | |a M�edicaments |x Conception. |0 (CaQQLa)201-0203461 | |
| 650 | 6 | |a Prot�eines. |0 (CaQQLa)201-0008150 | |
| 650 | 6 | |a M�edicaments |x Formes pharmaceutiques. |0 (CaQQLa)201-0025596 | |
| 650 | 7 | |a protein. |2 aat |0 (CStmoGRI)aat300206575 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Proteins |2 fast |0 (OCoLC)fst01079711 | |
| 650 | 7 | |a Drugs |x Dosage forms |2 fast |0 (OCoLC)fst00898801 | |
| 650 | 7 | |a Drugs |x Design |2 fast |0 (OCoLC)fst00898790 | |
| 650 | 7 | |a Protein drugs |2 fast |0 (OCoLC)fst01079679 | |
| 650 | 7 | |a Protein drugs |x Dosage forms |2 fast |0 (OCoLC)fst01079681 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Meyer, Brian K. | |
| 830 | 0 | |a Woodhead Publishing series in biomedicine ; |v no. 8. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568183 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568183 |z Texto completo |